Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sancho

Showing results (121-130 of 7,038) with videos related to

Pageof 704
Sort By:
Bulletin Du Cancer|April 1, 1974
[Problems posed by cessation of controlled therapeutic trials before agreed duration]H Sancho, R Flamant
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1973
Are controlled clinical trials unnecessary?H Sancho, M Hayat
Frontiers in Pharmacology|November 7, 2022
Editorial: Insights in pharmacology of anti-cancer drugs: 2021Patricia Sancho, Olivier Feron
Molecular & Cellular Oncology|June 17, 2016
More challenges ahead-metabolic heterogeneity of pancreatic cancer stem cellsChristopher Heeschen, Patricia Sancho
The Lancet. Infectious Diseases|March 28, 2017
Neisseria meningitidis and purpura fulminans in a woman with chronic liver diseasePere Domingo, Francesc Sancho
Nature|September 14, 2022
Fluorescence limitations overcome by engineering light-matter interactionsJuan-Carlos Sancho-García
The Journal of Physical Chemistry. A|July 13, 2006
Assessment of recently developed multicoefficient strategies for the treatment of pi-conjugated moleculesJ C Sancho-García
Anales Otorrinolaringologicos Ibero-Americanos|January 1, 1992
[Prolactinoma as atypical tumor of the nasopharynx]M Sancho, A Bonilla
Revista Clinica Espanola|March 8, 2011
[Internal medicine and palliative care]M A Sancho-Zamora
Enfermeria Clinica|May 3, 2011
[Tools for assessing the quality of cross-sectional epidemiological studies]M Consuelo Company Sancho
Pageof 704

Showing results (121-130 of 7,038) with videos related to

Sort By:
Pageof 704
Bulletin Du Cancer|April 1, 1974
[Problems posed by cessation of controlled therapeutic trials before agreed duration]H Sancho, R Flamant
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1973
Are controlled clinical trials unnecessary?H Sancho, M Hayat
Frontiers in Pharmacology|November 7, 2022
Editorial: Insights in pharmacology of anti-cancer drugs: 2021Patricia Sancho, Olivier Feron
Molecular & Cellular Oncology|June 17, 2016
More challenges ahead-metabolic heterogeneity of pancreatic cancer stem cellsChristopher Heeschen, Patricia Sancho
The Lancet. Infectious Diseases|March 28, 2017
Neisseria meningitidis and purpura fulminans in a woman with chronic liver diseasePere Domingo, Francesc Sancho
Nature|September 14, 2022
Fluorescence limitations overcome by engineering light-matter interactionsJuan-Carlos Sancho-García
The Journal of Physical Chemistry. A|July 13, 2006
Assessment of recently developed multicoefficient strategies for the treatment of pi-conjugated moleculesJ C Sancho-García
Anales Otorrinolaringologicos Ibero-Americanos|January 1, 1992
[Prolactinoma as atypical tumor of the nasopharynx]M Sancho, A Bonilla
Revista Clinica Espanola|March 8, 2011
[Internal medicine and palliative care]M A Sancho-Zamora
Enfermeria Clinica|May 3, 2011
[Tools for assessing the quality of cross-sectional epidemiological studies]M Consuelo Company Sancho
Pageof 704